Evidence guides
Plain-language guides distinguish case reports, toxicology findings, witness accounts, and incomplete records. For example, discussion of ibogaine half-life can help frame why timing and co-exposures matter in interpretation.
Independent information resource
Services
Guides, comparisons, and research summaries for examining ibogaine clinic deaths with attention to patterns, evidence limits, causation, screening, and monitoring.
Information tools, not clinical services
What this resource provides
A structured way to read difficult evidence.
Wicket Ash organizes information for people trying to understand ibogaine-associated fatalities without treating a reported outcome as a simple or certain causal story. The starting point is the broader overview of fatality patterns and causes, which keeps documented facts, plausible mechanisms, and unanswered questions distinct.
Our approach is shaped by the principles described in Wicket Ash’s mission and methods: independence, evidence before claims, plain language, causal precision, and harm awareness. These are information services only; they do not replace medical, legal, or emergency guidance.
04
Core information services designed to make evidence easier to compare without overstating what it can establish.
Context comparisons
Comparison tools examine recurring context without turning location or program type into a shortcut for causation, including questions raised around treatment centers in Mexico.
Research summaries
Concise summaries organize what published discussion can and cannot support. They can sit beside topic-specific material on ibogaine and alcohol addiction without implying a treatment recommendation.
Terms & questions
A working glossary and FAQ collection clarify terms such as screening, monitoring, adverse event, and confounding, including language relevant to ibogaine treatment for depression.
Evidence framework
Patterns are signals, not verdicts.
Ibogaine is associated with concerns about cardiac rhythm effects, which is why evidence summaries separate a suspected mechanism from a confirmed cause in any individual death. The U.S. Food and Drug Administration’s information on drug interactions illustrates why combined substances and metabolism can be relevant to risk assessment.
Questions about facilities can be explored through ibogaine treatment facilities, but a facility label alone cannot establish the adequacy of screening, monitoring, recordkeeping, or emergency response in a particular case.
“A careful account names what is known, what is plausible, and what remains unresolved.”
Comparison lens
From claim to evidence.
These comparison rows are a decision framework for reading records and summaries. They are not a clinical protocol and cannot determine what caused an individual outcome.
Question
What is directly documented?
Dates, stated substances, observed symptoms, tests, records, and the limits of each source.
Mechanism
What could have contributed?
Cardiac vulnerability, interactions, dose uncertainty, delayed care, and other factors may require separate evaluation.
Causation
What cannot be concluded?
Temporal proximity or a single reported detail does not by itself prove a cause of death.
Systems
What preventive questions remain?
How screening, observation, escalation, and emergency systems were described—and whether records are sufficient to assess them.
What this means in practice
Use the material to ask better questions.
Information about a death can be fragmented, retrospective, and emotionally difficult to assess. Wicket Ash’s guides are designed to keep uncertainty visible while making recurring concerns easier to identify. General background on drug interactions helps explain why single-factor explanations may be incomplete.
Location-specific searches, including material on ibogaine treatment in Seattle, should be read as topical context rather than evidence of safety, quality, or outcome at any provider. For immediate health concerns or suspected poisoning, contact local emergency services or a qualified health professional.